Sculptor Capital’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-750,400
Closed -$97.4M 451
2015
Q2
$97.4M Buy
+750,400
New +$97.8M 0.28% 76
2014
Q4
Sell
-250,000
Closed -$30.4M 828
2014
Q3
$30.4M Sell
250,000
-226,500
-48% -$27.5M 0.09% 203
2014
Q2
$56.2M Buy
476,500
+78,700
+20% +$9.26M 0.17% 143
2014
Q1
$47.8M Sell
397,800
-32,400
-8% -$3.85M 0.16% 138
2013
Q4
$47.9M Buy
430,200
+377,500
+716% +$37.5M 0.12% 208
2013
Q3
$4.86M Sell
52,700
-95,500
-64% -$8.64M 0.01% 540
2013
Q2
$12.5M Buy
+148,200
New +$12.3M 0.04% 393

Other funds holding TMO

Sculptor Capital's TMO Position: Q2 2026 in Review

Sculptor Capital opened a new position in Thermo Fisher Scientific (TMO) in Q2 2026: 41,000 shares worth $20.6M. The stake represents 0.17% of the portfolio and ranks #118 among its holdings. This is a return to the name: Sculptor Capital previously reported a position in TMO as recently as Q1 2023.

Sculptor Capital first reported a position in TMO in Q2 2013 and has held it in 16 quarters since. The position peaked at $610M in Q4 2013. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Sculptor Capital held 41,000 shares of Thermo Fisher Scientific worth $20.6M as of Q2 2026.
  • Thermo Fisher Scientific was a new Sculptor Capital position in Q2 2026.
  • Thermo Fisher Scientific made up 0.17% of Sculptor Capital's portfolio in Q2 2026, its #118 holding.
  • Sculptor Capital first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 16 quarters since.
  • Sculptor Capital's Thermo Fisher Scientific position peaked at $610M in Q4 2013.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Sculptor Capital's 13F filing for Q2 2026, filed 14 Aug 2026.